- NEWS AND VIEWS
A massive international effort has yielded multifaceted studies of more than 2,600 tumours from 38 tissues, generating a wealth of insights into the genetic basis of cancer.
By
-
Marcin Cieslik
-
Marcin Cieslik is in the Michigan Center for Translational Pathology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, USA, and in the Department of Computational Medicine and Bioinformatics, University of Michigan.
-
-
Arul M. Chinnaiyan
-
Arul M. Chinnaiyan is in the Michigan Center for Translational Pathology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, USA, and at the Howard Hughes Medical Institute.
-
Comprehensive genomic characterization of tumours became a major goal of cancer researchers as soon as the first human genome had been sequenced in 2001. Since then, advances in sequencing technology and analytical tools have allowed this research field to flourish. In six papers1–6 in this issue of Nature, the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium presents the most comprehensive and ambitious meta-analysis of cancer genomes so far. Unlike previous efforts that focused largely on protein-coding regions of the cancer genome, PCAWG analyses whole genomes. Each article scrutinizes an important aspect of cancer genetics — together, their findings will be key to understanding the full genetic complexity of cancer.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 578, 39-40 (2020)
doi: https://doi.org/10.1038/d41586-020-00213-2
References
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Nature 578, 82–93 (2020).
Rheinbay, E. et al. Nature 578, 102–111 (2020).
Alexandrov, L. B. et al. Nature 578, 94–101 (2020).
Li, Y. et al. Nature 578, 112–121 (2020).
Gerstung, M. et al. Nature 578, 122–128 (2020).
PCAWG Transcriptome Core Group et al. Nature 578, 129–136 (2020).
Priestley, P. et al. Nature 575, 210–216 (2019).
Nowell, P. C. Science 194, 23–28 (1976).
Fearon, E. R. & Vogelstein, B. Cell 61, 759–767 (1990).
Robinson, D. R. et al. Nature 548, 297–303 (2017).
Related Articles
-
Read the paper: The repertoire of mutational signatures in human cancer
-
Read the paper: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
-
Read the paper: Patterns of somatic structural variation in human cancer genomes
Read the paper: Pan-cancer analysis of whole genomes
Read the paper: The evolutionary history of 2,658 cancers
Read the paper: Genomic basis for RNA alterations in cancer
Huge whole-genome study of metastatic cancers